Articles tagged "Kidney transplantation"

2017 American Transplant Congress
Inferior Graft and Patient Survival After Living Donor Renal Transplantation of Negatively Selected Right Kidneys.
S. Yamanaga,^1,2,3 A. Posselt,¹ C. Freise,¹ C. Niemann,¹ A. Rosario,¹ D. Fernandez,¹ T. Kobayashi,³ A. Ahearn,⁴ M. Tavakol,¹ S.-M. Kang.¹
¹Department of Surgery, UCSF, San Francisco, CA; ²Department of General Surgery, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan; ³Department of Renal Transplant Surgery, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan; ⁴Department of Transplant Surgery, UMass Memorial Medical Center, Worcester, MA
Purpose: In living donor renal transplantation, the left kidney is usually chosen for anatomical reasons. The right kidney is sometimes chosen if it is believed…
2017 American Transplant Congress
Using Donors with False Positive HIV Tests – An Unexpected Benefit of the HOPE Act.
C. Durand,¹ S. Halpern,¹ G. Bismut,¹ B. Doby,¹ N. Desai,¹ A. Cameron,¹ S. Florman,² S. Lerner,² S. Huprikar,² J. Locke,³ S. Mehta,³ P. Stock,⁴ N. Neidlinger,⁵ D. Brown,¹ B. Haydel,² A. Redd,^1,6 A. Massie,¹ A. Tobian,¹ D. Segev.¹
¹JHU, Baltimore, MD; ²Mount Sinai, New York, NY; ³UAB, Birmingham, AL; ⁴UCSF, San Francisco, CA; ⁵Donor Network West, San Ramon, CA; ⁶NIH, Bethesda, MD
Deceased donors are screened for HIV infection using anti-HIV antibody (Ab) and nucleic acid testing (NAT). Historically, organs were discarded in cases of a suspected…
2017 American Transplant Congress
Cultural Competency of a Mobile, Customized Patient Education Tool for Improving Potential Kidney Transplant Recipients' Knowledge and Decision-Making.
D. Axelrod,¹ C. Kynard-Amerson,² D. Wojciechowski,³ K. Lentine,⁴ M. Schnitzler,⁴ J. Peipert,² A. Waterman.²
¹Surgery, East Carolina University, Greenville, NC; ²Medicine, UCLA, Los Angeles, CA; ³Medicine, Massachusetts General Hospital, Boston, MA; ⁴Transplant, Saint Louis University, St. Louis, MO
Patients with ESRD face a complex array of treatment options as a result of the revised kidney allocation system. Decision aids improve patient care through…
2017 American Transplant Congress
A Phase-Two, Randomised, Placebo-Controlled Trial: Belimumab in Renal Transplantation Targets Naïve, Activated Memory and Antibody Producing B Cells Whilst Sparing Regulatory B Cells.
G. Banham,^1,2 S. Flint,³ N. Torpey,² P. Lyons,¹ D. Shanahan,³ A. Gibson,³ A.-M. O'Sullivan,² R. Jones,^1,2,3 L. Devey,³ A. Richards,³ L. Erwig,³ C. Savage,³ K. Smith,^1,2 R. Henderson,³ M. Clatworthy.^1,2
¹Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom; ²Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom; ³GlaxoSmithKline, Stevenage, United Kingdom
This phase 2, double-blind, randomised controlled study (BEL114424) explores the safety and potential efficacy of addition of belimumab to standard of care in renal transplantation…
2017 American Transplant Congress
Identification of Antibody-Mediated Rejection After Kidney Transplantation by Specific MicroRNAs.
M. Matz,¹ F. Heinrich,² P. Durek,² C. Lorkowski,¹ K. Wu,³ N. Lachmann,⁴ K. Budde,¹ M.-F. Mashreghi.²
¹University Medicine Charité-Nephrology, Berlin, Germany; ²German Rheumatism Research Centre DRFZ, Berlin, Germany; ³University Medicine Charité-Pathology, Berlin, Germany; ⁴University Medicine Charité-Transfusion Medicine, Berlin, Germany
Antibody-mediated rejection (ABMR) is the major cause for allograft failure, since a curative therapy is lacking. There are also still challenges in ABMR diagnosis. The…
2017 American Transplant Congress
Outcomes of 100 ABO Incompatible Kidney Transplants: A Single US Center Experience.
S. Sethi, A. Vo, E. Huang, L. Varanasi, J. Choi, A. Peng, R. Najjar, S. Jordan.
Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA
IntroductionAcceptable patient and graft outcomes of ABO incompatible (ABOi) living donor kidney transplantation (LDKT) have been reported with the use of desensitization strategies. Data on…
2017 American Transplant Congress
Outcome of Kidney Transplantation from Deceased Octogenarian Donors.
P. Donato, L. Furian, C. Silvestre, F. Neri, C. Di Bella, M. Di Bello, P. Rigotti.
Kidney and Pancreas Transplantation Uniti, Padua University Hospital, Padua, Italy
In order to expand the donor pool, the utilization of kidneys otherwise discarded because of extremely old age or comorbidities has been evaluated.We retrospectively analyzed…
2017 American Transplant Congress
Plasma Extracellular Vesicles MicroRNA Signatures Associate with Graft Function Recovery Post-Acute Renal Allograft Injury.
V. Bontha, A. Fernandez-Pineros, D. Bagchi, D. Maluf, E. Rhone, V. Mas.
Surgery, UVA, Charlottesville
Background: Early host-allograft cell-to-cell communications have been reported to occur via extracellular vesicles (EVs)/protein-miRNA complexes that might determine early allograft outcomes like delayed graft function…
2017 American Transplant Congress
Risk Factors for Hospital Readmission with Urinary Tract Infections (UTIs) Following Kidney Transplantation (KT).
E. Minja, S. Jackson, A. Matas.
Surgery, UMN, Mpls, MN
UTIs are common causes of hospital readmissions after KT. Our objective is to determine predictors of hospital readmissions for UTI within 1 year after a…
2017 American Transplant Congress
Impact of Filgrastim Use on Maintenance Doses of Immunosuppressants and Clinical Outcomes in Renal Transplant Patients.
C. Kane,¹ K. Lang,² T. Rendulic,¹ M. Goetz,¹ R. Evans,¹ K. Trobaugh,¹ J. Berger.¹
¹University of Kentucky HealthCare, Lexington, KY; ²University of Kentucky College of Pharmacy, Lexington, KY
Introduction: There are limited data assessing the outcomes of filgrastim for the treatment of neutropenia among renal transplant patients. We investigated the association of filgrastim…